BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 4, 2007
View Archived Issues
Novel antiinflammatory agents disclosed in recent patent literature
Read More
Studies reveal potential of CS-917 in type 2 diabetes
Read More
Studies advance immunomodulating agents for diabetes
Read More
Phase II findings warrant advancement of ispinesib for breast cancer
Read More
New data on treatments for diabetic complications: neuropathy, gastroparesis
Read More
Proof of concept obtained for HMPL-004 in ulcerative colitis
Read More
Recent patents impart new therapeutic agents for respiratory disorders
Read More
FemmePharma initiates clinical trial for pain associated with breast disease
Read More
Bayer introduces more convenient formulation of Kogenate FS
Read More
4SC completes enrollment for a phase IIa trial for rheumatoid arthritis
Read More
Cylene Pharmaceuticals initiates phase II trial of Quarfloxin for cancer
Read More
New data indicate activity of perifosine in multiple myeloma
Read More
FDA approves clinical trials of ralfinamide for neuropathic pain
Read More
Wilex to file SPA for CA9-SCAN
Read More
Karo Bio delays development of KB-5359 for dyslipidemia
Read More
New agents for renal and urological disorders reported by Toray
Read More
Novel long-acting GLP-1 analogues presented at the ADA meeting
Read More
Novel adenosine A2B receptor antagonist improves insulin sensitivity in vivo
Read More
Newly identified frog-derived ribonuclease could be a future cancer therapy
Read More
Wyeth and Karo Bio extend atherosclerosis collaboration
Read More
Positive phase I/II results for ALKS-29 in alcohol-dependent patients
Read More
Phase I data indicate activity of Quadramet in multiple myeloma
Read More
Positive results of subcutaneous methylnaltrexone extension study
Read More
Santhera inlicenses omigapil for congenital muscular dystrophy
Read More
New data support role of Velcade in front-line multiple myeloma treatment
Read More
SIRT2: a new target in Parkinson's disease
Read More
Tamiflu approved in 30 mg and 45 mg doses
Read More